214 related articles for article (PubMed ID: 36580661)
1. Recognition Mechanisms between a Nanobody and Disordered Epitopes of the Human Prion Protein: An Integrative Molecular Dynamics Study.
Mollica L; Giachin G
J Chem Inf Model; 2023 Jan; 63(2):531-545. PubMed ID: 36580661
[TBL] [Abstract][Full Text] [Related]
2. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
Rossetti G; Giachin G; Legname G; Carloni P
Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
[TBL] [Abstract][Full Text] [Related]
3. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
Abskharon RN; Giachin G; Wohlkonig A; Soror SH; Pardon E; Legname G; Steyaert J
J Am Chem Soc; 2014 Jan; 136(3):937-44. PubMed ID: 24400836
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into the critical role of gallate moiety of green tea catechins in modulating prion fibrillation, cellular internalization, and neuronal toxicity.
Admane N; Srivastava A; Jamal S; Sharma R; Kundu B; Grover A
Int J Biol Macromol; 2022 Dec; 223(Pt A):755-765. PubMed ID: 36368361
[TBL] [Abstract][Full Text] [Related]
5. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics study of the dominant-negative E219K polymorphism in human prion protein.
Jahandideh S; Jamalan M; Faridounnia M
J Biomol Struct Dyn; 2015; 33(6):1315-25. PubMed ID: 25027605
[TBL] [Abstract][Full Text] [Related]
7. NMR structural studies of human cellular prion proteins.
Biljan I; Ilc G; Giachin G; Legname G; Plavec J
Curr Top Med Chem; 2013; 13(19):2407-18. PubMed ID: 24059340
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
[TBL] [Abstract][Full Text] [Related]
9. Backbone NMR assignments of the C-terminal domain of the human prion protein and its disease-associated T183A variant.
Sanz-Hernández M; De Simone A
Biomol NMR Assign; 2021 Apr; 15(1):193-196. PubMed ID: 33590433
[TBL] [Abstract][Full Text] [Related]
10. Dynamic diagnosis of familial prion diseases supports the β2-α2 loop as a universal interference target.
Meli M; Gasset M; Colombo G
PLoS One; 2011 Apr; 6(4):e19093. PubMed ID: 21552571
[TBL] [Abstract][Full Text] [Related]
11. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
Palaniappan C; Narayanan RC; Sekar K
ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.
Biljan I; Giachin G; Ilc G; Zhukov I; Plavec J; Legname G
Biochem J; 2012 Sep; 446(2):243-51. PubMed ID: 22676969
[TBL] [Abstract][Full Text] [Related]
13. Epitope-specific anti-PrP antibody toxicity: a comparative
Adhikari UK; Tayebi M
Prion; 2021 Dec; 15(1):155-176. PubMed ID: 34632945
[TBL] [Abstract][Full Text] [Related]
14. Modulation of prion polymerization and toxicity by rationally designed peptidomimetics.
Srivastava A; Sharma S; Sadanandan S; Gupta S; Singh J; Gupta S; Haridas V; Kundu B
Biochem J; 2017 Jan; 474(1):123-147. PubMed ID: 27803245
[TBL] [Abstract][Full Text] [Related]
15. A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.
Kurt TD; Jiang L; Bett C; Eisenberg D; Sigurdson CJ
J Biol Chem; 2014 Apr; 289(15):10660-10667. PubMed ID: 24596090
[TBL] [Abstract][Full Text] [Related]
16. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
Zhang J; Zhang Y
J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
[TBL] [Abstract][Full Text] [Related]
18. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras.
Cong X; Bongarzone S; Giachin G; Rossetti G; Carloni P; Legname G
J Biomol Struct Dyn; 2013; 31(8):829-40. PubMed ID: 22934595
[TBL] [Abstract][Full Text] [Related]
19. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1.
Baral PK; Wieland B; Swayampakula M; Polymenidou M; Rahman MH; Kav NN; Aguzzi A; James MN
Acta Crystallogr D Biol Crystallogr; 2012 Nov; 68(Pt 11):1501-12. PubMed ID: 23090399
[TBL] [Abstract][Full Text] [Related]
20. Biophysical characterization of oligomerization and fibrillization of the G131V pathogenic mutant of human prion protein.
Zhang M; Zhang H; Yao H; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1223-1232. PubMed ID: 31735962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
